| Product Code: ETC10201001 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Active and Intelligent Packaging in Pharmaceutical Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Active and Intelligent Packaging in Pharmaceutical Market - Industry Life Cycle |
3.4 Suriname Active and Intelligent Packaging in Pharmaceutical Market - Porter's Five Forces |
3.5 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Suriname Active and Intelligent Packaging in Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for pharmaceutical products in Suriname |
4.2.2 Growing focus on improving drug safety and efficacy |
4.2.3 Rising adoption of advanced packaging technologies in the pharmaceutical industry |
4.3 Market Restraints |
4.3.1 High initial investment costs associated with active and intelligent packaging solutions |
4.3.2 Stringent regulatory requirements and compliance standards for pharmaceutical packaging |
4.3.3 Limited awareness and understanding of the benefits of active and intelligent packaging among pharmaceutical companies in Suriname |
5 Suriname Active and Intelligent Packaging in Pharmaceutical Market Trends |
6 Suriname Active and Intelligent Packaging in Pharmaceutical Market, By Types |
6.1 Suriname Active and Intelligent Packaging in Pharmaceutical Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Near Field Communication (NFC), 2021 - 2031F |
6.1.4 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Radio Frequency Identification (RFID), 2021 - 2031F |
6.1.5 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Time-Temperature Indicators (TTIs), 2021 - 2031F |
6.1.6 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Gas Scavengers, 2021 - 2031F |
6.1.7 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Moisture Control Packaging, 2021 - 2031F |
6.1.8 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Thermochromic Ink Packaging, 2021 - 2029F |
6.1.9 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Others, 2021 - 2029F |
6.1.10 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Others, 2021 - 2029F |
6.2 Suriname Active and Intelligent Packaging in Pharmaceutical Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Product Authentication, 2021 - 2031F |
6.2.3 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Anti-Counterfeiting Measures, 2021 - 2031F |
6.2.4 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Patient Compliance Monitoring, 2021 - 2031F |
6.2.5 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Supply Chain Management, 2021 - 2031F |
6.2.6 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Others, 2021 - 2031F |
7 Suriname Active and Intelligent Packaging in Pharmaceutical Market Import-Export Trade Statistics |
7.1 Suriname Active and Intelligent Packaging in Pharmaceutical Market Export to Major Countries |
7.2 Suriname Active and Intelligent Packaging in Pharmaceutical Market Imports from Major Countries |
8 Suriname Active and Intelligent Packaging in Pharmaceutical Market Key Performance Indicators |
8.1 Percentage increase in the adoption of active and intelligent packaging solutions by pharmaceutical companies in Suriname |
8.2 Number of new product launches incorporating active and intelligent packaging technologies |
8.3 Reduction in product recalls and instances of counterfeit drugs due to the implementation of active and intelligent packaging solutions in the pharmaceutical market in Suriname |
9 Suriname Active and Intelligent Packaging in Pharmaceutical Market - Opportunity Assessment |
9.1 Suriname Active and Intelligent Packaging in Pharmaceutical Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Suriname Active and Intelligent Packaging in Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Suriname Active and Intelligent Packaging in Pharmaceutical Market - Competitive Landscape |
10.1 Suriname Active and Intelligent Packaging in Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Suriname Active and Intelligent Packaging in Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here